Order by 12pm AEDT, Monday to Friday, for same-day shipping!

Retatutide 6MG

$299.00

40 in stock

By Buying 

3 Bottles

You can get 10% off

By Buying 

6 Bottles

You can get 15% off

By Buying 

9 Bottles

You can get 20% off

To get a discount, simply add products to the cart and continue to the checkout page, and the discount will automatically be applied.

Retatrutide is an advanced injectable peptide currently in clinical development, designed to target three major metabolic hormone receptors: GLP-1, GIP, and Glucagon. This triple-receptor activity gives it unmatched potential in fat loss, metabolic regulation, and cardiovascular support – making it the most comprehensive peptide of its kind to date. Developed by pharmaceutical giant Eli Lilly, Retatrutide is showing superior results compared to well-known peptides like Semaglutide and Tirzepatide. Early trial data reveals record-setting weight loss, improved cardiovascular markers, and promising longevity-enhancing effects, positioning it as a future frontrunner in both medical and performance applications.

Product Summary

Feature Details
Peptide Name Retatrutide
Mechanism Triple receptor agonist: GLP-1, GIP, Glucagon
Primary Benefits Fat loss, cardiovascular health, longevity support
Administration Subcutaneous injection (once weekly or split dose)
Starting Dosage 0.25mg to 0.5mg per week
Max Suggested Dosage Up to 2.5–3mg per week based on tolerance
Refrigeration Required Yes, 2°C–8°C after reconstitution
Suitable For Fat loss plateaus, metabolic resistance, longevity protocols
Clinical Status Phase 2 trials completed; ongoing Phase 3 investigations

Why Retatrutide Stands Out

Retatrutide represents a major leap forward in peptide-based fat loss. By activating three key hormone pathways instead of one, it delivers powerful results in reducing body fat, improving metabolic markers, and increasing energy expenditure – all while preserving lean muscle. Initial clinical trials have shown up to 24.2% body weight reduction over just 48 weeks, a result that surpasses even the best-performing GLP-1-based compounds. It also shows promise in lowering blood pressure, reducing non-HDL cholesterol, and aiding in liver and cardiovascular health. What sets Retatrutide apart is its multi-dimensional action. While GLP-1 and GIP reduce appetite and improve insulin sensitivity, the Glucagon receptor component boosts thermogenesis and fat burning, giving it a unique edge for those looking to lose fat while maintaining muscle and metabolic output. Whether you’re looking for a powerful fat loss solution, a break through a plateau, or a long-term strategy to support metabolic and hormonal health – Retatrutide offers a robust, science-backed option with evolving data behind it.

Invivo Benefits

Retatrutide doesn’t just work on the surface – it interacts at a cellular and hormonal level to restore balance, increase energy output, and support long-term transformation. With consistent use, users report improved sleep, fewer cravings, better insulin response, and more stable energy. Its effects go beyond aesthetics, supporting healthy ageing processes such as cellular repair and autophagy – vital components for longevity and wellbeing.

Benefits of Retatrutide

  • Clinically Proven Weight Loss
    • Up to 24.2% weight reduction in Phase 2 trials
    • Ideal for those who didn’t respond well to Semaglutide or Tirzepatide
  • Comprehensive Cardiovascular Support
    • Reduces non-HDL cholesterol by up to 26.9%
    • May assist in lowering risk of heart disease, stroke, and inflammation
  • Anti-Ageing & Cellular Repair
    • Promotes autophagy and may reduce senescent cell buildup
    • Supports mitochondrial health and energy production
  • Triple-Receptor Action
    • Combines appetite control, fat burning, and energy regulation in one compound

Suggested Use Protocol

  • Begin with 0.25mg to 0.5mg per week
  • Gradually increase to 2.5mg–3mg per week, based on your response
  • Inject subcutaneously once a week, or split into two smaller doses for better tolerance
  • Use consistently for 12 to 16+ weeks to achieve optimal outcomes
  • Store the reconstituted peptide at 2°C–8°C in the refrigerator

    Which product’s lab result would you like to receive?

    Our RAD140 3rd party lab test will be emailed to you once submitted.

    Our RAD150 3rd party lab test will be emailed to you once submitted.

    Our MK677 3rd party lab test will be emailed to you once submitted.

    Our MK2866 3rd party lab test will be emailed to you once submitted.

    Our SR9009 3rd party lab test will be emailed to you once submitted.

    Our LGD4033 3rd party lab test will be emailed to you once submitted.

    Our S4 3rd party lab test will be emailed to you once submitted.

    Our S23 3rd party lab test will be emailed to you once submitted.

    Our GW0742 3rd party lab test will be emailed to you once submitted.

    Our GW501516 3rd party lab test will be emailed to you once submitted.

    Our YK11 3rd party lab test will be emailed to you once submitted.

    Our GHRP-2 3rd party lab test will be emailed to you once submitted.

    Our CJC-1295 with DAC 3rd party lab test will be emailed to you once submitted.

    Our TB-500 3rd party lab test will be emailed to you once submitted.

    Our BPC-157 3rd party lab test will be emailed to you once submitted.

    Our GHRP-6 3rd party lab test will be emailed to you once submitted.

    Our HGH Frag 176-191 3rd party lab test will be emailed to you once submitted.

    Our HCG 3rd party lab test will be emailed to you once submitted.

    Our PT-141 3rd party lab test will be emailed to you once submitted.

    Our SHK-CU 3rd party lab test will be emailed to you once submitted.

    Our Ipamorelin 3rd party lab test will be emailed to you once submitted.

    Our Retatutide 3rd party lab test will be emailed to you once submitted.

    Our Tizepatide 3rd party lab test will be emailed to you once submitted.

    Our MELANOTAN II 3rd party lab test will be emailed to you once submitted.

    Our Tesamorelin 3rd party lab test will be emailed to you once submitted.

    This is a test group.

    Description

    Retatrutide is an advanced injectable peptide currently in clinical development, designed to target three major metabolic hormone receptors: GLP-1, GIP, and Glucagon. This triple-receptor activity gives it unmatched potential in fat loss, metabolic regulation, and cardiovascular support – making it the most comprehensive peptide of its kind to date.

    Developed by pharmaceutical giant Eli Lilly, Retatrutide is showing superior results compared to well-known peptides like Semaglutide and Tirzepatide. Early trial data reveals record-setting weight loss, improved cardiovascular markers, and promising longevity-enhancing effects, positioning it as a future frontrunner in both medical and performance applications.

    Product Summary

    Feature Details
    Peptide Name Retatrutide
    Mechanism Triple receptor agonist: GLP-1, GIP, Glucagon
    Primary Benefits Fat loss, cardiovascular health, longevity support
    Administration Subcutaneous injection (once weekly or split dose)
    Starting Dosage 0.25mg to 0.5mg per week
    Max Suggested Dosage Up to 2.5–3mg per week based on tolerance
    Refrigeration Required Yes, 2°C–8°C after reconstitution
    Suitable For Fat loss plateaus, metabolic resistance, longevity protocols
    Clinical Status Phase 2 trials completed; ongoing Phase 3 investigations

    Why Retatrutide Stands Out

    Retatrutide represents a major leap forward in peptide-based fat loss. By activating three key hormone pathways instead of one, it delivers powerful results in reducing body fat, improving metabolic markers, and increasing energy expenditure – all while preserving lean muscle.

    Initial clinical trials have shown up to 24.2% body weight reduction over just 48 weeks, a result that surpasses even the best-performing GLP-1-based compounds. It also shows promise in lowering blood pressure, reducing non-HDL cholesterol, and aiding in liver and cardiovascular health.

    What sets Retatrutide apart is its multi-dimensional action. While GLP-1 and GIP reduce appetite and improve insulin sensitivity, the Glucagon receptor component boosts thermogenesis and fat burning, giving it a unique edge for those looking to lose fat while maintaining muscle and metabolic output.

    Whether you’re looking for a powerful fat loss solution, a break through a plateau, or a long-term strategy to support metabolic and hormonal health – Retatrutide offers a robust, science-backed option with evolving data behind it.

    Invivo Benefits

    Retatrutide doesn’t just work on the surface – it interacts at a cellular and hormonal level to restore balance, increase energy output, and support long-term transformation.

    With consistent use, users report improved sleep, fewer cravings, better insulin response, and more stable energy. Its effects go beyond aesthetics, supporting healthy ageing processes such as cellular repair and autophagy – vital components for longevity and wellbeing.

    Benefits of Retatrutide

    • Clinically Proven Weight Loss
      • Up to 24.2% weight reduction in Phase 2 trials
      • Ideal for those who didn’t respond well to Semaglutide or Tirzepatide
    • Comprehensive Cardiovascular Support
      • Reduces non-HDL cholesterol by up to 26.9%
      • May assist in lowering risk of heart disease, stroke, and inflammation
    • Anti-Ageing & Cellular Repair
      • Promotes autophagy and may reduce senescent cell buildup
      • Supports mitochondrial health and energy production
    • Triple-Receptor Action
      • Combines appetite control, fat burning, and energy regulation in one compound

    Suggested Use Protocol

    • Begin with 0.25mg to 0.5mg per week
    • Gradually increase to 2.5mg–3mg per week, based on your response
    • Inject subcutaneously once a week, or split into two smaller doses for better tolerance
    • Use consistently for 12 to 16+ weeks to achieve optimal outcomes
    • Store the reconstituted peptide at 2°C–8°C in the refrigerator

    Reviews

    There are no reviews yet.

    Be the first to review “Retatutide 6MG”

    Your email address will not be published. Required fields are marked *